We have converted the former solar electrical plant THEMIS (French Pyrenees) into an atmosphericČerenkov detector called CELESTE, which records gamma rays above 30 GeV (7 × 10 24 Hz). Here we present the first sub-100 GeV -2detection by a ground based telescope of a gamma ray source, the Crab nebula, in the energy region between satellite measurements and imaging atmospherič Cerenkov telescopes. At our analysis threshold energy of 60 ± 20 GeV we measure a gamma ray rate of 6.1 ± 0.8 per minute. Allowing for 30% systematic uncertainties and a 30% error on the energy scale yields an integral gamma ray flux of I(E > 60 GeV) = 6.2 +5.3 −2.3 × 10 −6 photons m −2 s −1 . The analysis methods used to obtain the gamma ray signal from the raw data are detailed. In addition, we determine the upper limit for pulsed emission to be ¡12% of the Crab flux at the 99% confidence level, in the same energy range. Our result indicates that if the power law observed by EGRET is attenuated by a cutoff of form e −E/E 0 then E 0 < 26 GeV. This is the lowest energy probed by ǎ Cerenkov detector and leaves only a narrow range unexplored beyond the energy range studied by EGRET.
The CAT (Cherenkov Array at Thémis) imaging telescope, equipped with a veryhigh-definition camera (546 fast phototubes with 0.12 • spacing surrounded by 54 larger tubes in two guard rings) started operation in Autumn 1996 on the site of the former solar plant Thémis (France). Using the atmospheric Cherenkov technique, it detects and identifies very high energy γ-rays in the range 250 GeV to a few tens of TeV. The instrument, which has detected three sources (Crab nebula, Markarian 421 and Markarian 501), is described in detail.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.